WP1130 inhibits USP9X, USP5, UCHL1, USP14, and UCH37 in liver and breast cancer [217,218,219], exhibiting anti-tumor activity by downregulating the anti-apoptotic protein MCL−1 and upregulating the pro-apoptotic protein p53 [220]. Here, USP9X is linked to neoplasm.